CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 47 filers reported holding CATALYST BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $548,000 | -67.8% | 133,449 | -66.1% | 0.14% | -62.7% |
| Q2 2021 | $1,704,000 | -13.7% | 393,449 | +0.5% | 0.37% | -18.6% |
| Q1 2021 | $1,974,000 | +65.3% | 391,618 | +107.0% | 0.46% | +49.7% |
| Q4 2020 | $1,194,000 | +33.3% | 189,161 | -9.3% | 0.31% | +29.1% |
| Q3 2020 | $896,000 | -29.1% | 208,478 | -3.1% | 0.24% | -33.4% |
| Q2 2020 | $1,263,000 | +34.2% | 215,237 | 0.0% | 0.36% | -18.3% |
| Q1 2020 | $941,000 | – | 215,237 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |